Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

An Efficacy Trial of The Toolkit for Optimal Recovery After Concussion

29. oktober 2026 opdateret af: Jonathan Greenberg, Massachusetts General Hospital

The goal of this study is to test the efficacy of the Toolkit for Optimal Recovery after Concussion (TOR-C), a brief live-video mind-body program. aiming to prevent chronic concussion symptoms and optimize recovery.

Studieoversigt

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

260

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år til 35 år (Voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  1. Sustained a concussion 3-10 weeks earlier
  2. At least mild anxiety symptoms (score ≥ 5 on GAD-7 anxiety scale)
  3. Age 18-35
  4. English fluency and literacy
  5. Ability and willingness to participate in study procedures, assessments, and intervention
  6. Access to a smartphone or computer with internet access
  7. Cleared for participation by clinic/study staff

Exclusion Criteria:

  1. Participation in mind-body or CBT treatment in the past 3 months
  2. Concussion in the past 2 years that resulted in symptoms lasting 3 months or more / current or previous complicated or moderate/severe TBI
  3. Practice of mindfulness techniques > 45 minutes/week in the past 3 months
  4. Change in psychotropic medications (e.g., antidepressant, anxiolytics) in the past 6 weeks
  5. Uncontrolled bipolar disorder, psychosis, active substance dependence, self reported current active suicidal ideation with plan and/or intent
  6. Pregnancy
  7. Serious comorbidity expected to worsen in the next 6 months
  8. Secondary gains that may bias motivation (e.g., pending disability claim)

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Forebyggelse
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Dobbelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Toolkit for Optimal Recovery after Concussion (TOR-C)

A 4-week mind-body program delivered via live video (Zoom) 1:1 with a clinician delivering mind-body and cognitive-behavioral skills.

TOR-C is a brief behavioral mind-body program delivered remotely via live video over four weekly 45-minute sessions, with approximately 10 minutes of daily home practice. It targets anxiety and fear-avoidance factors to prevent chronic concussion symptoms, combining mind-body skills (e.g., mindfulness, deep breathing, acceptance), light cognitive-behavioral skills, skills for gradual return to activity, and concussion psychoeducation.

Aktiv komparator: Health Enhancement after Concussion (HE-C)

A 4-week program delivered via live video (Zoom) 1:1 with a clinician delivering psychoeducation and information about healthy living after a concussion

HE-C is an attention-matched active control program delivered remotely via live video over four weekly 45-minute sessions, with approximately 10 minutes of daily home practice. It provides general health education after concussion (e.g., sleep, nutrition, physical activity) without the specific skills included in TOR-C.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Post-Concussion Symptom Scale (PCSS)
Tidsramme: Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)

Measures the severity of concussion symptoms (e.g., headache, fatigue, dizziness, difficulty concentrating). This is the study's primary outcome; efficacy is judged mainly on reducing these symptoms.

Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Generalized Anxiety Disorder scale (GAD-7)
Tidsramme: Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)

Measures the severity of anxiety symptoms. (Also used at screening, where a score ≥5 is required for eligibility.)

Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)
Patient Health Questionnaire-9 (PHQ-9)
Tidsramme: Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)

Measures the severity of depression symptoms.

Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)
Fear Avoidance Behavior after Traumatic Brain Injury (FAB-TBI)
Tidsramme: Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)

Measures fear-avoidance behavior, i.e., avoiding activities out of fear they will worsen symptoms. A core mechanism in the fear-avoidance model.

Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)
Symptom Catastrophizing Scale
Tidsramme: Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)

Measures the tendency to catastrophize concussion symptoms (magnifying, ruminating on, or feeling helpless about them).

Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)
Cognitive and Affective Mindfulness Scale-Revised (CAMS-R)
Tidsramme: Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)

Measures mindfulness, i.e., present-moment awareness and acceptance of thoughts and feelings.

Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)
Behavioral Response to Illness Questionnaire (BRIQ): Limiting behavior subscale
Tidsramme: Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)

Measures the tendency to limit or avoid various activities in response to medical conditions

Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)
Pittsburgh Sleep Quality Index (PSQI)
Tidsramme: Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)

An exploratory outcome which measures sleep quality over the past month.

Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)
PROMIS Cognitive Function
Tidsramme: Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)

An exploratory outcome which measures self-reported cognitive function (e.g., perceived problems with memory, attention, and thinking).

Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)
WHO Disability Assessment Schedule (WHODAS 2.0; 12-item version)
Tidsramme: Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)

It is 12-item measure of health-related functioning and disability across daily activities (e.g., cognition, mobility, self-care, social participation) over the past 30 days, with higher scores indicating greater disability.

Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Anslået)

1. juni 2027

Primær færdiggørelse (Anslået)

1. december 2030

Studieafslutning (Anslået)

1. december 2030

Datoer for studieregistrering

Først indsendt

29. oktober 2026

Først indsendt, der opfyldte QC-kriterier

29. oktober 2026

Først opslået (Faktiske)

9. november 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

9. november 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

29. oktober 2026

Sidst verificeret

1. oktober 2026

Mere information

Begreber relateret til denne undersøgelse

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

JA

IPD-planbeskrivelse

We plan to share our study protocol, analysis plan, data dictionary, and de-identified data from all measures described under "outcome measures"

IPD-delingstidsramme

Data from this study will be deposited into the Vivli database no later than one year of the completion of the funded project period

IPD-delingsadgangskriterier

Interested parties can create an account in the Vivli Database and submit a request to access study data

IPD-deling Understøttende informationstype

  • STUDY_PROTOCOL
  • SAP

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner